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ABSTRACT: Infections with multiresistant pathogens are a lead-
ing cause for mortality worldwide. Just recently, the World Health
Organization (WHO) increased the threat rating for multiresistant
Pseudomonas aeruginosa to the highest possible level. With this
background, it is crucial to develop novel materials and proce-
dures in the ﬁght against multiresistant pathogens. In this study,
we present a novel antimicrobial material, which could ﬁnd
applications as a wound dressing or antimicrobial coating. Lectins
are multivalent sugar-binding proteins, which can be found in a
variety of plants and bacteria, where they are associated with
bioﬁlm formation. By immobilizing lectin B on a protein-based
hydrogel surface, we provided the hydrogel with the ability to
immobilize (“catch”) pathogens upon contact. Furthermore,
another hydrogel layer was added which inhibits bioﬁlm forma-
tion and releases a highly potent antimicrobial peptide to eradicate microorganisms (“kill”). The composite hydrogel showed a
high antimicrobial activity against the reference strain Pseudomonas aeruginosa PAO1 as well as against a carbapenem-resistant
clinical isolate (multiresistant Gram-negative class 4) and may thus represent a novel material to develop a new type of
antimicrobial wound dressings to prevent infections with this problematic pathogen of burn or other large wounds.
■ INTRODUCTION
Antimicrobial infections have become one of the major health
issues of our century, especially with nosocomial infections being
among the most challenging tasks to handle for healthcare
facilities. While plenty of literature deals with this problem and
hundreds of research facilities worldwide are working on this
topic, no country or institution can claim to be able to solve this
problem or to come up with an ultimate solution in a reasonable
time for the future. According to the World Health Organization
(WHO), infections are the second highest cause for mortality
worldwide, and according to the European Center for Disease
Control (ECDC), more than 4 million patients are aﬀected by
nosocomial infection every year in Europe alone,1 with immune-
suppressed patients especially being life-threatened. In early 2017,
carbapenem-resistant P. aeruginosa strains were classiﬁed to be
among the most threatening pathogens with the highest demand
for novel antibiotics by the WHO.2 Due to these alarming num-
bers and facts, novel procedures, methods, and materials must
be developed to keep this tremendous health problem at bay.
Hydrogels, 3D networks which can incorporate huge
amounts of water while being insoluble, have recently attracted
increasing attention as a unique class of biomaterials. They are
soft materials which have recently been used frequently in
cosmetics,3 for drug delivery,4−6 and for tissue engineering.7−10
Most hydrogels have ﬂexible properties and can easily be casted
into the desired form. Additionally, many hydrogel systems can
be modiﬁed and designed according to the intended use by
adjusting their physio-chemical properties and by functionaliz-
ing the material postproduction to add antimicrobial features.
In this context, hydrogels with inherent antimicrobial activity,
e.g., positively charged polymers,11−13 are distinguished from
hydrogels with acquired antimicrobial activity, e.g., by encap-
sulating with or coupling to antimicrobial compounds, like
antibiotics, antimicrobial peptides (AMP), or nanopar-
ticles.14−16 These unique material features qualify hydrogels
as promising and potent materials in the ﬁght against pathogens
at many fronts, and several studies have been presented on the
use of hydrogels as depots for drug delivery14,15,17,18 or as
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antimicrobial coatings.19−21 Furthermore, there are numerous
examples of hydrogels as biosensors, where the surface of a
hydrogel is functionalized to enable bacterial binding and detec-
tion. This immobilization of microorganisms can be realized
with diﬀerent mechanisms, e.g., with aptamers, antibodies, conca-
navalin A, or porous surfaces, which can capture bacteria.22−26
Generally, the main purpose is the immobilization of bacteria to
enable detection and classiﬁcation techniques for pathogens
with the aim to reduce detection limits to optimize sensitivity.27
In this study, however, a “capture-and-kill” approach was
intended, developing a concept in which high numbers of patho-
genic bacteria can be immobilized on a hydrogel surface, fol-
lowed by subsequent killing of the attached organisms. A com-
posite hydrogel material was used, which combines and exhibits
diﬀerent antimicrobial features. A proximal (upper) hydrogel
layer facing the infection site is responsible for the bacterial
immobilization, while a distal (lower) layer exhibits antimicro-
bial eﬀects, resulting in subsequent killing of pathogens. This
material could serve as a novel compound in composite wound
dressings. While exudate is absorbed from the wound, path-
ogens are immobilized onto the hydrogel and subsequently
killed by the (released) compound. Especially for severe infec-
tions with multiresistant bacteria, this would signiﬁcantly facil-
itate the burden and thus possibly enable or, at least, support
the immune system to overcome the infection on its own.
For the proximal layer in our concept, a serum albumin-
based protein hydrogel was used. Serum album is among the
most abundant proteins in the human body and is responsible
for the maintenance of the oncotic pressure.28 The formation of
the hydrogel matrix is assisted by the four-armed amine reactive
cross-linking agent, tetrakis (hydroxymethyl) phosphonium
chloride (THPC).29 Within minutes, water insoluble, highly
resilient hydrogels can be formed from diﬀerent protein back-
bones.30−32 These biocompatible hydrogels are easy to handle
due to their high mechanical stability, easy to produce due to
the straightforward use of a liquid two component system to
initiate gel-to-sol transition, can be casted into any possible
form, and exhibit high stabilities toward external stimuli (pH,
temperature, etc.).30,33,34 Furthermore, the material can easily
be modiﬁed postproduction due to the numerous reactive
hydroxy-, amine-, or thiol-groups in the BSA molecules, which
can serve as targets for the introduction of novel, potentially
antimicrobial, moieties into the hydrogel. This highly resilient
layer is equipped with the capability of catching pathogenic
microorganisms. For this purpose, the hydrogel was modiﬁed
with lectin molecules, a class of sugar binding proteins, which
are present in many plants and bacteria, and are capable of
binding several sugar moieties at once with varying aﬃnities for
diﬀerent types of sugars due to their multivalency.35,36 In bac-
teria, lectins are associated with cell recognition processes,
especially in bioﬁlm formation.37 As they are capable of binding
to a variety of glycosylated structures as well as sugar moieties
of the bacterial surface,38 they can be used in the detection and
immobilization of bacteria.25,39,40 In our setup, a fusion protein
of the P. aeruginosa tetrameric lectin B (LecB) and YFP as a
reporter domain, which has recently been published as an
adaptor for the reversible immobilization of human cells,32 was,
in the application presented here, covalently bound to the
surface of the hydrogel backbone via thiol reactive cross-linker
molecules, while maintaining its functionality concerning
ﬂuorescence and sugar binding capability. By using this
approach, which was inspired by the lectin-mediated cell
recognition and binding processes in the bioﬁlm formation of
several pathogens,41−43 bacteria could be immobilized on the
proximal hydrogel layer via sugar-mediated binding to the
immobilized lectin.
The second and distal part of the composite material is
composed of a ﬁbril-forming amino acid hydrogel. Fmoc-
protected phenylalanine (fmocF) has been described to form
ﬁbrils under physiological conditions, which can bind water at
very low concentrations (0.1% (w/v)) with one molecule being
capable of entrapping 21500 water molecules,44 making it a
highly potent supergelator. Compared to the proximal protein
hydrogel layer, these ﬁbrillar hydrogel materials can bind 25−
200-fold more water based on the dry substance, which qualiﬁes
them as very potent water reservoirs, which are typically
essentially required to build up wound dressing layers. The
prototypic example, fmocF, is obtainable and aﬀordable in the
kilogram range and readily forms hydrogels under physiological
pH values and temperatures due to π−π interactions of the ring
structures.45−47 Due to this very gentle gelation procedure, it is
a convenient material for the encapsulation of a variety of anti-
microbial agents. Furthermore, the enantiomer of L-phenylalanine
has been shown to prevent or disassemble bioﬁlm of several
pathogenic microorganisms, e.g., Staphylococcus aureus and
P. aeruginosa,48−50 while maintaining its potential to form
hydrogels. To further increase the antimicrobial eﬀect of the
composite hydrogels, the BP100-based AMP C14R was
incorporated into the lower layer of the hydrogel. BP100 was
originally derived from a library of cecropin−melittin (apitoxin
derived from bee venom) peptides.51 Recently, Torcato et al.52
reported on a novel BP100 analogue with a signiﬁcantly
improved activity against both Gram-negative (E. coli, Klebsiella
pneumoniae, and P. aeruginosa) and Gram-positive (S. aureus,
Streptococcus pneumoniae, and Enterococcus faecium) bacteria due
to its interaction with and disruption of the bacterial
membrane.52
Confocal laser scanning microscopy (CLSM) revealed a
stable immobilization of the lectin onto the material, while a
subsequent catching of P. aeruginosa PAO1 and E. coli Tuner
(DE3) was performed with an optimized lectin concentration
of 250 μM. Fmoc-D-F showed to have inhibitory eﬀects on the
bioﬁlm formation of P. aeruginosa PAO1, while encapsulated
AMP showed to have strong antimicrobial eﬀects on both
E. coli Tuner (DE3) and P. aeruginosa PAO1. The composite
material could be used to catch and kill both E. coli Tuner
(DE3) and P. aeruginosa PAO1 cells. To evaluate the potential
of this concept for the treatment of infections with multidrug-
resistant bacteria, we also evaluated a clinical Pseudomonas
aeruginosa isolate. This strain expressed the New Delhi
metalloproteinase-type carbapenemase and was classiﬁed as
“4MRGN” with resistance against all four classes of antibiotics
(acylaminopenicillines, cephalosporines, carbapenems, and
chinolones), and it is available for ﬁrst line therapy against
Pseudomonas. All of the results indicate a successful immo-
bilization and subsequent killing of the relevant strain for both
the well-described laboratory strains as well as for freshly
isolated, carbapenem-resistant P. aeruginosa PAO1, which has
recently be classiﬁed as a critical risk factor for human health
with the highest priority for the development of novel anti-
microbial strategies.2
■ MATERIALS AND METHODS
Ampicillin, tetracycline, bromophenol blue, CaCl2, K2HPO4, KCL,
KOH, KH2PO4, LB medium, lysozyme, HCl, NaCl, and tris were
ordered from Roth (Carl Roth GmbH and Co. KG, Karlsruhe,
Biomacromolecules Article
DOI: 10.1021/acs.biomac.8b00089
Biomacromolecules 2018, 19, 2472−2482
2473
Germany). BMOE linker, bovine serum albumin, crystal violet,
comassie brilliant blue, D-mannose agarose, DMSO, ethanol, fmoc-
D-F−OH, fmoc-L-F−OH, resazurin, and THPC were ordered from
Sigma-Aldrich (St. Louis, Missouri, USA). EDTA was ordered from
Thermo Fisher Scientiﬁc (Waltham, Massachusetts, USA), and fmoc-
FF−OH was ordered from Bachem (Bachem AG, Bubendorf,
Switzerland). The bacterial strains and plasmids of E. coli Tuner
(F−ompT hsdSB (rB−mB−) gal dcm lacY1(DE3), Pseudomonas
aeruginosa PAO,53 and CFP-tagged P. aeruginosa PAO154 were
generated with the miniTn7(Gm))PA1/04/03-ecfp-a GmR plasmid,
and eGFP-tagged E. coli Tuner (DE3) was generated with pET22b-
eGFP.
Recombinant Lectin Production and Puriﬁcation. For each
experiment, the expression strain was freshly transformed with 1 μL of
yellow ﬂuorescent protein−LecB (YFP-LecB) plasmid (180 ng/μL)
being mixed with chemical competent E. coli BL21 Tuner (Merck
Millipore, Darmstadt, Germany). The mixture was then incubated for
45 min on ice, followed by 42 °C for 1 min and subsequent incubation
on ice for 3 min. Prewarmed lysogeny broth (LB) medium (800 μL)
was added, and the cells were incubated at 37 °C for 1 h, followed by
plating 50 μL of the cell suspension on selective LB-amp (100 μg/mL)
medium and incubation overnight at 37 °C. The next day, one clone
was picked and transferred to 50 mL of selective LB-amp medium and
grown at 37 °C overnight. The next day, expression cultures were
inoculated with an optical density (OD) of 0.1 in 200 mL of 0.4%
glucose and 100 μg/mL ampicillin in a 2 L ﬂask and grown at 37 °C to
an OD of 0.6, followed by induction with 1 mM isopropyl-β-d-
thiogalactoside (IPTG) and a temperature shift to 21 °C. After 16 h of
cell growth, cells were harvested by centrifugation at 3.000g and 4 °C
for 30 min and suspended in 15 mL of 100 mM Tris-HCL (1 mg/mL
Lysozyme) pH 8.0, incubated for 30 min on ice, sonicated for 15 min
at 40% intensity (6 cycles) on ice, and ﬁnally centrifuged at 10.000g
and 4 °C for 30 min. Puriﬁcation of YFP-LecB by aﬃnity chroma-
tography (D-mannose Agarose Beads M6400 Sigma-Aldrich, St. Louis,
Missouri, USA) was carried out at 37 °C; the column was equilibrated
with 3 mL of 100 mM Tris-HCl, pH 8.0, and the cell extract was
loaded onto the column and incubated for 1 h at 37 °C, followed by
subsequent washing with 15 mL of 100 mM Tris-HCl and 150 mM
NaCl, pH 8.0. The YFP-LecB fusion protein was eluted with 4 bead
volumes of 100 mM Tris-HCl, pH 8.0, containing 20 mM D-mannose.
Samples were further concentrated using Vivaspin 20 microconcen-
trators (Mr cutoﬀ, 10 kDa) and washed with 100 mM Tris-HCl,
pH 8.0. The amount of protein was determined with a Pierce BCA
protein assay at 562 nm at a Tecan200 M ﬂuorescence reader (Tecan
Group Ltd., Man̈nedorf, Switzerland).
BSA Hydrogel Production and Functionalization. BSA
hydrogels were produced by mixing 1:1 20% (w/v) BSA stock solu-
tion with THPC at appropriate concentrations30 in a ibidi μ slide,
resulting in ﬁnal dimensions of the hydrogel of 10 mm × 10 mm × 3 mm
(width, length, thickness). Bismaleimideoethan (BMOE) linker
(150 μL, 10 mM in DMSO) was added and incubated for 16 h at
21 °C, followed by extensive washing twice with 150 μL of PBS. The
next day, 80 μL of the LecB solution (500, 250, 125, and 62.5 nm) was
added and incubated for 2 h at 21 °C to enable proper cross-linking
between sulfhydryl groups in the BMOE linker and the LecB-YFP
protein. Unbound LecB was washed oﬀ with 100 μL of PBS, and the
successful modiﬁcation was monitored with CLSM (Carl Zeiss Ag,
Oberkochen, Germany) at a wavelength of 514 nm.
Peptide Hydrogel Production and Drug Loading. fmoc-L-F−
OH or fmoc-D-F−OH was diluted in DMSO (100 mg/mL) and
mixed with phosphate buﬀer (10 mM Na2HPO4; 42 mM NaH2PO4
in demin water, pH 7.4) in a 12.5:1 ratio to receive 0.8% (w/v)
ﬁbrillary hydrogels. Hydrogels were prepared in a ibidi μ slide,
resulting in ﬁnal dimensions of the hydrogel of 10 mm × 10 mm ×
3 mm (width, length, thickness). To load hydrogels with AMP, the
appropriate volume of AMP (5 mg/mL) was added prior to solid-
iﬁcation to obtain the appropriate concentration (2, 4, and 8 μg/mL).
Hydrogels were stored at 4 °C.
Composite Hydrogel Production. Fibrillary hydrogels were
prepared and loaded with AMP as described before. The second layer
was cast onto the ﬁrst hydrogel, where it polymerized within minutes
and functionalized with LecB in situ.
Toxicity Testing. P. aeruginosa53,56 and E. coli Tuner (DE3) were
grown to an OD600 of 0.1, induced with 1 mM IPTG, and 100 μL of
bacterial solution (106 cells/ml) was transferred onto the composite
hydrogels. After 2 h of incubation, the bacteria were stained with 50 μL
of 0.1 mg/mL (w/v) resazurin. After 1 h, the cells were thoroughly
washed with PBS. Viable bacteria transformed resazurin into resoruﬁn.
The ﬂuorescence of resoruﬁn was monitored with a CLSM Microscope
(Carl Zeiss AG, Oberkochen, Germany) at a wavelength of 561 nm.
Synthesis of an AMP. The AMP CSSGSLWRLIRRFLRR is a
derivative of BP10055 and was synthesized automatically on a
0.10 mmol scale using standard fmoc solid phase peptide synthesis
techniques with the microwave synthesizer (CEM GmbH, Kamp-
Lintfort, Germany). A resin preloaded with serine was used and
provided in the reactor and washed with dimethylformamide (DMF).
The fmoc protecting group was removed with 20% (v/v) piperidine in
DMF and initialized with microwaves, followed by being washed with
DMF. Amino acids were added in 0.2 mol equiv to the reactor, and
then HBTU 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium-hex-
aﬂuorophosphate) in a 0 and 5 mol equiv was dosed into the amino
acid solution, followed by the addition of 2 mol equiv of N,N-
diisopropylethylamine (DIEA). The coupling reaction was done with
microwaves in a few minutes, and then the resin was washed in DMF.
These steps were repeated for all amino acids in the sequence. The last
step of the last amino acid was the ﬁnal deprotection. Once the
synthesis was completed, the peptide was cleaved in 95% (v/v)
triﬂuoracetic acid (TFA), 2.5% (v/v) triisopropylsilane (TIS), and
2.5% (v/v) H2O for 1 h. The peptide residue was precipitated and
washed with cold diethyl ether (DEE) by centrifugation. The peptide
precipitate was then allowed to dry under vacuum to remove residual
ether, and the peptide was puriﬁed using reversed phase preparative
high-performance liquid chromatography (Waters GmbH, Eschborn,
Germany) in an acetonitrile/water gradient under acidic conditions on
a Phenomenex C18 Luna column (5 mm pore size, 100 Å particle size,
250 _ 21.2 mm). In the following puriﬁcation, the peptide was
lyophilized on a freeze-dryer (Labconco, Kansas City, MO, USA) for
storage prior to use. The puriﬁed peptide mass was veriﬁed by liquid
chromatography mass spectroscopy (Waters GmbH, Eschborn,
Germany).
AMP and fmoc-D-F Toxicity on P. aeruginosa and E. coli.
Overnight cultures of P. aeruginosa PAO153,56 and E. coli Tuner (DE3)
(Novagen, Merck KgaA, Darmstadt, Germany) were diluted to a cell
number of 106 colony forming units/ml (CFU) and diluted in M63
minimal medium. The AMP peptide was added to ﬁnal concentrations
of 2, 4, and 8 mg/mL, and fmoc-D-F−OH was diluted to 0.05, 0.1, 0.3,
and 0.5% (w/v) ﬁnal concentrations; untreated cells were used as a
control. After incubation overnight at 30 °C and 200 rpm, 100 μL of
the samples was transferred into a 96-well plate, spiked with 20 μL of
0.1% resazurin, covered with aluminum foil, incubated for 2 h, and
measured with a Tecan200 M ﬂuorescence reader (Tecan Group Ltd.,
Man̈nedorf, Switzerland) at an excitation wavelength of 535 nm and an
emission wavelength of 595 nm.
Bioﬁlm Inhibition of fmoc-D-F. The bioﬁlm assay was conducted
according to Hochbaum et al.48 An overnight culture of P. aeruginosa
PA01 was diluted to 1:100 in tryptic soy broth (TSB), and 2 mL of the
suspension was transferred into 6-well plates. The appropriate amount
of fmoc-F−OH was added to each well (0.04−0.1% fmoc-F−OH
(w/v)) and incubated for 24 h at 37 °C without shaking. After removal
of the supernatant and being washed with PBS, adherent cells were
stained with crystal violet (500 μL of 0.1% (w/v) solution to each
well), which binds to negative charges molecules in the cell membrane.
The wells were gently shaken for 30 min, followed by being washed
twice with demin water to remove unbound crystal violet. To quantify
bioﬁlm formation, the wells were incubated with 500 μL of 95%
ethanol for 15 min until all of the cells were unstained. Samples were
analyzed with a Tecan200 M ﬂuorescence reader (Tecan Group Ltd.,
Man̈nedorf, Switzerland) at an absorption of 595 nm.
Peptide Hydrogel Degradation. Hydrogels were produced as
described above, transferred into 1.5 mL Eppendorf tubes, and covered
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with PBS, pH 7.4. For mixed hydrogels, fmoc-D-F−OH and fmoc-
L-FF−OH were mixed 1:1 (w/w) and diluted in DMSO prior to the
hydrogel preparation. Tubes were stored at 4, 21, and 37 °C. At the
appropriate times, hydrogel was removed from the solution, dried with
a highly absorbent paper, and weighed.
Catching of P. aeruginosa and E. coli on Hydrogel. P. aeruginosa
and E. coli were grown to an OD600 of 0.1 in LB supplemented with
100 μg/mL of ampicillin, induced with 1 mM isopropyl-β-d-
thiogalactoside (IPTG), and transferred onto a BSA hydrogel
functionalized with diﬀerent concentrations of LecB (see above).
The hydrogel was incubated with 30 μL of bacterial solution (OD 1)
for 30 min, followed by being washed twice with PBS to remove
unbound bacteria. The potential to capture bacteria with diﬀerent
LecB concentrations was analyzed with a Zeiss Confocal Microscope
(Carl Zeiss Ag, Oberkochen, Germany) at 405 nm for P. aeruginosa
and 488 nm for E. coli.
Toxicity of the Drug-Loaded fmoc-D-F−OH Hydrogel on
P. aeruginosa and E. coli. To test the toxicity of the hydrogel, fmoc-
D-F−OH hydrogel alone and fmoc-D-F−OH hydrogel loaded with
AMP were prepared as described earlier. An overnight culture of
P. aeruginosa PAO153,56 and E. coli Tuner (DE3) was diluted to
107 CFU/ml, and 200 μL of the cell suspension was incubated with
100 μL of the drug-loaded hydrogel for 4, 8, 16, and 24 h. As a control,
cells were spiked with the adequate amount of PBS instead of a
hydrogel. After incubation at 30 °C and 200 rpm, 100 μL of the
samples was transferred into a 96-well plate, spiked with 20 μL of 0.1%
resazurin, covered with aluminum foil, incubated for 2 h, and measured
with a Tecan200 M ﬂuorescence reader (Tecan Group Ltd.,
Man̈nedorf, Switzerland) at an excitation wavelength of 535 nm and
an emission wavelength of 595 nm.
Composite Hydrogel Eﬀect on Multi/Carbapenem-Resistant
P. aeruginosa. Composite hydrogels loaded with AMP and
functionalized with YFP-LecB were produced as described above, as
well as composite hydrogels without YFP-LecB and composite hydrogels
without AMP. Carbapenem-resistant P. aeruginosa (106 cells/ml,
100 μL) cells were transferred onto the hydrogel. After 2 h, the
bacteria were washed subsequently with 200 μL of PBS, followed by
being washed with 200 μL of PBS containing 20 mM mannose.
Bacteria were plated on LB agar plates and grown overnight at 37 °C.
The next day, the CFUs were counted with FIJI software.
Statistical Analysis. All error bars represent standard deviations.
Statistical signiﬁcance was tested with a student’s t test with α = 0.5.
■ RESULTS AND DISCUSSION
LecB is a tetrameric protein which is known to bind diﬀerent
sugars with diﬀerent aﬃnities and is used by the producing bac-
teria to immobilize themselves on abiotic surfaces, for example,
during bioﬁlm formation or the establishment of infec-
tions.37,57−59 This natural concept has been used to develop
Figure 1. Schematic illustration of the capture-and-kill mechanism of
the hydrogel material. The top hydrogel layer consists of bovine serum
albumin (BSA) chemically cross-linked with THPC and is subse-
quently surface functionalized with a recombinant fusion protein of
P. aeruginosa PAO1 LecB and YFP as a reporter domain to enable the
reversible immobilization of pathogenic bacteria on its surface. The
bottom layer consists of fmoc-protected D-phenylalanine hydrogels,
which are loaded with an AMP. In a two-step reaction, bacteria are ﬁrst
immobilized on the hydrogel surface, followed by subsequent
sequestration of the AMP from the lower hydrogel and a consequent
killing of the immobilized microorganism.
Figure 2. Hydrogel modiﬁcation and catching of bacteria. (A) The top line shows an unfunctionalized piece of hydrogel, while the lower layer shows
a piece of the functionalized material. The hydrogel is functionalized with a 10 μM bispeciﬁc maleimide cross-linker, which targets cysteines in the
yellow ﬂuorescent protein−LecB (YFP-LecB) fusion product for 16 h. YFP-LecB (62.5−500 nM) is immobilized for 2 h on the hydrogel surface
while maintaining its functionality and visualized with a Zeiss laser scanning confocal microscope at 514 nm. (B,C) CLSM of E. coli Tuner (DE3),
which intracellularly expresses eGFP, was visualized at 405 nm (B), and P. aeruginosa, which intracellularly expresses CFP, was visualized at 405 nm
(C). The modiﬁed hydrogel was incubated with bacteria for 2 h, followed by extensive washing with PBS.
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lectins for the immobilization of bacteria on surfaces to produce
sensors for the detection of bacteria.60,61 We decided to directly
use the lectin-mediated immobilization of bacteria for the con-
struction of a composite material for the catching of human
pathogens on synthetic surfaces, like a hydrogel modiﬁed with
LecB from P. aeruginosa. The combination of lectins and
composite hydrogels may oﬀer the possibility to develop novel
antimicrobial wound dressings, especially for the treatment of
early infected wounds. The principal behind this would be an
immobilization of the pathogens on the wound surface, thereby
resulting in their local reduction and decreasing the infective
threat for the aﬀected tissue. In a second step, the immobilized
pathogen, in our concept, would be eradicated by a suitable
drug, for example an AMP (Figure 1).
The modiﬁcation of the hydrogel with YFP-LecB was per-
formed with a dimaleimide linker which readily reacts with
cysteines under physiological conditions.62 To investigate the
successful modiﬁcation with LecB, a variant of the protein was
produced, representing a translational fusion construct with an
additional yellow ﬂuorescent protein domain (YFP) at the
N-terminus of LecB (YFP-LecB). This YFP contains two
naturally occurring cysteine residues in its 3D structure, one of
which is located in the center of the barrel structure, while the
other is solvent accessible on the outer surface (PDB: 2JAD)
and is thus available for further cross-linking reactions, e.g., with
a maleimide linker reagent. The modiﬁcation of the material
surface was analyzed by measuring the ﬂuorescence of the YFP
domain of the fusion construct using CLSM (Figure 2A). This
modiﬁcation appears to be considerably stable and robust since
it is maintained even after extensive washing steps. Because the
lectin can bind to a variety of diﬀerent sugars in bacterial sur-
face structures, it was reasonable to expect that direct capturing
of bacterial pathogens could be probable on a surface which is
coated with functional sugar-binding moieties.60,63,64 Diﬀerent
LecB concentrations were used to determine the immobilization
of bacteria in combination with E. coli and P. aeruginosa, two well
characterized bacterial strains, which were labeled by the expres-
sion of eGFP (E. coli) and CFP (P. aeruginosa). For lectin con-
centrations below 62.5 nM, a signiﬁcant diﬀerence in the poten-
tial of the gel to catch bacteria could not be observed. However,
with increasing concentrations, more E. coli and P. aeruginosa
were detected on the hydrogel surface (Figure 2B,C). The best
results were achieved for 250 nM, indicated by a situation
where both P. aeruginosa and E. coli cells densely covered most
of the surface of the materials. As for the binding capacity,
approximately 4 × 107 bacteria could be immobilized per
square mm hydrogel (quantiﬁed using the FIJI software, ver-
sion 1.51d65). Above that, higher concentrations did not
increase binding capacities but unexpectedly an overall decrease
of the organisms was detected, accompanied by the formation
of large gaps with no measurable bacterial ﬂuorescence on the
hydrogels surface. This “peeling” may most probably be
Figure 3. Hydrogel properties. (A) Residual weight of ﬁbril forming the lower hydrogel layer over time. The addition of fmoc-FF enhances the half-
live. (B) Antimicrobial activity of fmoc-D-F monomers. P. aeruginosa PAO1 and E. coli Tuner (DE3) were incubated overnight with diﬀerent fmoc-
D-F concentrations (0.05−0.5%). The amount of living cells was measured subsequently with 0.1% resazurin after 2 h. (C,D) To test the potential
bioﬁlm inhibition eﬀect of fmoc-D-F, P. aeruginosa PAO1 was grown in 6-well plates in the presence of diﬀerent (0.05−0.1%) fmoc-D-F
concentrations. Crystal violet stains the membranes of cells and thus indicates and visualizes the bioﬁlm formation of P. aeruginosa PAO1. The
supernatant was removed from the 6-well plates, and the absorbance at 505 nm was measured.
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explained by the formation of microcolony-like bacterial
aggregates mediated by the natural occurring onset of bioﬁlm
formation (probably mediated also by LecB), which can be
suspected to be exposed to signiﬁcantly higher shear forces
during washing and is thus detached from the surface.
Since several pathogens can form stable bioﬁlms on biotic
and abiotic surfaces, depending on their initial cell titer and the
incubation time with these bioﬁlm architectures serving to
protect them from external environmental factors, this would
inevitably lead to the undesired growth of an even more potent
reservoir of pathogens. Therefore, we added an additional
functionality to the functionalized BSA hydrogel, represented
by a second distal layer. This second layer is composed of fmoc-
protected D-phenylalanine (fmoc-D-F) or its dipeptide fmoc-
protected D-diphenylalanine (fmoc-D-FF), which both readily
form hydrogels under physiological conditions by π−π
interactions between the aromatic rings44 and exhibit slight
antimicrobial eﬀects.45 As the most basic but important material
property, the stability of the resulting hydrogels manufactured
from fmoc-D-F, fmoc-D-FF was measured as the residual wet
weight after incubation in solution as described earlier.30,31 The
physical principal behind the formation of hydrogels by fmoc-
D-F or other protected small aromatic amino acids is the
formation of nanoﬁbrils between the monomers by π−π
stacking.45 Hydrogels formed from fmoc-D-F were signiﬁcantly
less stable compared to their counterparts composed of pure
fmoc dipeptide (fmoc-L-FF) (Figure 3A). However, it was
possible to increase the stability of fmoc-D-F hydrogels
signiﬁcantly by the addition of fmoc-L-FF, which may be an
eﬀect of the additional aromatic ring possibly serving as a
molecular branch connection to increase the degree of cross-
linking between individual nanoﬁbrils, which in turn may result
in more stable materials. However, the exact mechanism has yet
to be clariﬁed.45,47 For the intended application of the hydrogel
system as an antimicrobial wound dressing, the lifetime of a few
days, as observed in our experiments, may already be in a suﬃ-
cient range, as changing wound dressings is typically required
after several hours or a few days. Another beneﬁcial feature of
using the non-natural D-enantiomer of phenylalanine is its antimi-
crobial eﬀect.48,49,66 As Figure 3B indicates, the fmoc-protected
enantiomers of phenylalanine already severely inﬂuence the
viability of P. aeruginosa, as well as of E. coli, as model organ-
isms. Additionally, fmoc-D-F has been described as a potent
inhibitor of bioﬁlm formation and is known to promote bioﬁlm
disruption.48−50 As bioﬁlms might act as a protective barrier
which can shield bacteria from harmful agents, such as anti-
biotics or peptides,67,68 it would be beneﬁcial to prematurely
avoid spoiling and subsequent undesired bioﬁlm formation of
the material.
Figure 3C,D shows the comparison of normal bioﬁlm forma-
tion of P. aeruginosa, one of the most potent bioﬁlm
producers,69,70 and bioﬁlm formation in the presence of
fmoc-D-F. Crystal violet stains bacteria in a deep blue color71
and visualizes the bioﬁlm formation of P. aeruginosa (Figure 3D),
Figure 4. Eﬀect of encapsulated AMP. (A) To test the eﬀect and optimal concentration for the used strains with the AMP, P. aeruginosa PAO1 and
E. coli Tuner (DE3) were incubated with diﬀerent concentrations (0−8 μg/mL) of AMP overnight, followed by the determination of the cell viability
0.1% resazurin at an excitation wavelength of 535 nm and an emission wavelength of 595 nm. (B) Time and concentration dependent eﬀects of AMP
encapsulated into fmoc-D-F hydrogels. After 24 h of incubation with 8 μg/mL, no more cell viability could be detected for both P. aeruginosa PAO1
(B) and E. coli Tuner (DE3) (C).
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while the removed, crystal violet stained bacteria in Figure 3C
quantify the extent of bioﬁlm formation according to
Hochbaum et al.48 Both the visual and the quantitative results
indicate eﬃcient inhibition of P. aeruginosa bioﬁlm formation
by fmoc-D-F and can thus be expected to support inhibition of
bioﬁlm formation by the hydrogel material itself on its surface.
To rapidly and eﬃciently eradicate pathogens on the
materials surface, it is necessary to involve an eﬃcient and
fast acting bactericidal compound in order to kill bacteria and
to avoid the formation of resistance toward antibiotics. C14R is
a short, cationic AMP derived from the peptide BP100 (MIC
5−7.5 μg/mL against Pseudomonas species55) isolated from bee
venom, which, as a prototype or lead structure, could be
optimized by rational design to increase potency against both
Gram-positive and Gram-negative strains.51,52 To initially test
the eﬀect of C14R on E. coli and P. aeruginosa strains, bacteria
were incubated overnight with increasing peptide concentra-
tions (0−8 μg/mL). Whereas concentrations from 4 μg/mL
were suﬃcient to eradicate E. coli, eﬃcient killing of P. aeruginosa
required higher concentrations of 8 μg/mL or higher, sug-
gesting a higher resistance of P. aeruginosa probably due to the
increased mechanical stability of its outer membrane.
To equip the composite hydrogel system with this strong
antimicrobial eﬀect, the AMP was encapsulated into fmoc-D-F
hydrogels, which could easily be polymerized under physio-
logical conditions in the presence of the peptide. Subsequently,
the release of the peptide from the material and the time-
dependency of the antimicrobial eﬀect were investigated by incu-
bating the pathogens in the presence of peptide-loaded hydrogels
harboring the same peptide concentrations (0−8 μg/mL) as
used in the mentioned setup in liquids (Figure 4A). Samples
were taken after 4, 8, 16, and 24 h from bacterial solution, and
the viability of the pathogens was analyzed. The concentrations,
which were found to eradicate all bacteria in liquid culture,
proved to be eﬃcient also for the drug-loaded hydrogels,
indicated by the fact that the killing of E. coli or P. aeruginosa
approximated 100% after 16 h (Figure 4B,C).
After testing the proximal (catching) and distal (killing)
layers alone, the complete concept with both layers uniﬁed in a
functional composite material was evaluated. The hydrogel was
produced by ﬁrst polymerizing the distal fmoc-D-F layer,
followed by polymerization of the proximal second, protein
hydrogel layer directly on top of it, resulting in a mechanically
stable sandwich. P. aeruginosa and E. coli, intracellularly
expressing eGFP and CFP, were incubated with the hydrogel
system, and their viability regarding diﬀerent peptide concen-
trations was investigated using CLSM. To additionally monitor
the viability of the immobilized bacteria, resazurin was used to
stain the microorganisms. Resazurin is a cell permeable dye
which is reduced by dehydrogenases in living organisms to
resoruﬁn, which emits red light upon excitation.72 Therefore,
living organisms emit red light as visible in Figure 5A for E. coli
and Figure 5B for P. aeruginosa, while dead cells do not show
any red ﬂuorescence. With increasing peptide concentrations,
the viability decreased drastically until the complete disappear-
ance of the visible living pathogens from the hydrogels surface,
indicating the successful release of the AMP and the subsequent
killing of the immobilized bacteria with a high eﬃciency.
To evaluate the potential of this concept for the treatment of
infections with highly resistant bacteria, we next evaluated a
clinical isolate from the lesion of the left foot of a 61-year old
patient who was bitten by a scorpion during a holiday in Kenya.
The strain expressed the New Delhi metalloproteinase-type
carbapenemase and was resistant to all of the tested antibiotics,
with the exception of colistin. Despite intensive systemic and
local treatment, this exceptionally resistant and aggressive
Pseudomonas strain caused extensive necrosis, and the aﬀected
lower limb had to be amputated to prevent life threatening
septicemia. The 4MRGN P. aeruginosa, which was isolated from
a patient, was incubated for 2 h with the composite hydrogel,
Figure 5. Eﬀect of the drug-loaded hydrogel on pathogens. (A,B) CLSM of eGFP-labeled E. coli Tuner (DE3) visualized at 405 nm (A), and CFP-
labeled P. aeruginosa PAO1 visualized at 405 nm (B). Pathogens were incubated for 2 h on the hydrogel, followed by extensive washing with PBS.
Cells were further stained with 0.1% resazurin, resoruﬁn was excited at 554 nm, and viable cells are indicated in red. For E. coli Tuner (DE3), no
more viable cells were observed for 4 μg/mL of the peptide concentration and higher ,while for P. aeruginosa PAO1, no more viable cells were
detected for 8 μg/mL of peptide concentration.
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followed by sequential and extensive washing of the hydrogel
surface with PBS and a mannose-containing solution. Mannose
is a sugar with a high aﬃnity for LecB and can thus replace the
glycosylated structures on the bacterial surfaces, resulting in the
elution of the bacteria from the hydrogel surface.
To get a complete view, three diﬀerent variants of materials
were used. The ﬁrst one was neither functionalized with LecB
nor loaded with AMP and thus served as a negative control.
Pathogens were not immobilized on the surface and could be
completely removed with PBS (Figure 6). Subsequently, eluted
cells were plated on LB agar plates to evaluate their viability in a
CFU assay (Figure 6). A subsequent additional washing step
including mannose, however, did not increase the number of
removed bacteria and CFU in the plate assay. In a second exper-
iment, the material was modiﬁed with LecB but not loaded with
AMP, resulting in a fully viable bacteria on the surface. Only
marginal amounts of cells could be removed by washing with
PBS, whereas when mannose was included in the washing solu-
tion, bacteria were eluted almost completely (Figure 6). In the
third experiment, hydrogels both functionalized with LecB and
loaded with AMP were used. Again, bacteria could not be
removed with PBS, while bacteria, which were removed with a
mannose-containing solution, did not show any growth on the
plates, leading to the conclusion that the used AMP already
killed all of the bacteria on the hydrogels surface (Figure 6).
In summary, the novel composite hydrogel does not only
work like shown in our proof-of-principle experiment involving
the common, well-characterized but honestly less harmful labo-
ratory strain P. aeruginosa PAO1 but also for clinically relevant,
multiresistant bacteria of the genus P. aeruginosa. As the cap-
turing step of the cells is mediated by the LecB-dependent
binding of sugar residues in the polymeric structures on the
bacterial cell surface and LecB has a relatively broad speciﬁcity
regarding its (sugar) target, it can be expected that a variety of
bacteria can be bound by LecB. Furthermore, at present, there
is a huge variety of lectins,73 which may be of certain interest
for capturing speciﬁc bacteria. Since the capturing layer of our
system can easily be functionalized with probably any protein
via amine- or thiol-reactive cross-linking agents, as described
here, it is principally open to be adapted to every cellular target,
Figure 6. Eﬀect of the composite hydrogel on MRGN4 P. aeruginosa. Testing of the material with multiresistant Gram-negative class 4 P. aeruginosa.
Three diﬀerent hydrogel variants ((1) no LecB; (2) no AMP, only LecB; and (3) both AMP and LecB) proved the feasibility of the designed
material and the usage against the multiresistant pathogens.
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depending on the adapter protein used, with lectins being only
one example. We consider the novel capture-and-kill material
presented here to be a promising tool in the ﬁght against the
increasing threat from multiresistant pathogens, which may
serve as a starting point to develop tailor-made wound dress-
ings to avoid or treat clinical infections with these pathogens in
the future.
■ CONCLUSION
A composite material was developed which combines a protein
hydrogel functionalized with LecB and a ﬁbrillar fmoc
phenylalanine-based gel as a reservoir for water and anti-
bacterial compounds for the later development of novel wound
dressings. The functionality of the lectin-mediated binding of
Pseudomonas aeruginosa laboratory strains and clinical isolates
to the material was demonstrated. The killing of the caught
bacterial cells by the ﬁbrillar and drug-loaded compartment was
accomplished and shown in diﬀerent experiments. We believe
that this catch-and-kill concept will help to overcome problems
in the surgical care of larger wounds in hospitals with these
aggressive, carbapenem-resistant strains, since a dangerous and
essential mechanism for the establishment of severe infections
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